The adverse outcome in the basal subtype is usually attributed to GATA3 loss, promoting tumour suppressor gene downregulation and transition from epithelial to mesenchymal type leading to increased invasiveness and spread of the tumour [24]. The gene discussed is GATA3; the disease is neoplasm.